IM Cannabis Corp IMCC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
IM Cannabis Announces Closing of the Sale of IMC Holdings and Its European-Focused Operations, Strengthens Balance Sheet
-
IM Cannabis Announces Closing of US$1.31 Million Registered Direct Offering of Common Shares
-
IM Cannabis Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
IM Cannabis Announces Pricing of US$1.31 Million Registered Direct Offering of Common Shares
-
IM Cannabis Enters Non-Binding Agreement to Acquire 51% of Space Defense Innovations, Operating in the European Tactical UAS Market
-
IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing
-
IM Cannabis Shares Commence Trading on 30:1 Consolidated Basis
-
IM Cannabis Announces Intention to Complete 30:1 Share Consolidation to Support Nasdaq Minimum Bid Price Compliance
Trading Information
- Previous Close Price
- $1.33
- Day Range
- $1.31–1.46
- 52-Week Range
- $1.20–77.10
- Bid/Ask
- $1.46 / $1.50
- Shares Outstanding
- 1.65M
- Market Cap
- $839,450.19
- Volume/Avg
- 8,489 / 3M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.01
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 44
- Website
- https://www.imcannabis.com
Valuation
|
Metric
|
IMCC
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.01 |
Price/Cash Flow | — |
Price/Earnings
IMCC
Financial Strength
|
Metric
|
IMCC
|
|---|---|
Quick Ratio | 0.29 |
Current Ratio | 0.56 |
Interest Coverage | −2.73 |
Quick Ratio
IMCC
Profitability
|
Metric
|
IMCC
|
|---|---|
Return on Assets (Normalized) | −50.67% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −80.49% |
Return on Assets
IMCC
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|>ctQM@? | LOCK|n@XXd | $70B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|^dwD&?M | LOCK|S%!@ | $48B | |||
| Haleon PLC ADR
HLN
| LOCK|<vVK>db | LOCK|jvn | $44B | |||
| Zoetis Inc Class A
ZTS
| LOCK|!R<Y&Nj? | LOCK|N% | $33B | |||
| Viatris Inc
VTRS
| LOCK|Ts$&tj< | LOCK|nV@ | $21B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|PND | LOCK|LB | $12B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|%>fMC<k | LOCK|!$# | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|B^@&t> | LOCK|Z>V | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|>Dd&n?T | LOCK|pVTz | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|!s&q?D | LOCK|ycg | $2B |
United States